<- Go Home
Epigenomics AG
Epigenomics AG does not have significant operations. Previously, it was involved in liquid biopsy for the early detection of cancer. The company was founded in 1998 and is based in Heidelberg, Germany.
Market Cap
EUR 700.1K
Volume
375.00
Cash and Equivalents
EUR 1.2M
EBITDA
EUR 3.2M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
EUR 122.3K
Profit Margin
89.79%
52 Week High
EUR 2.30
52 Week Low
EUR 0.50
Dividend
N/A
Price / Book Value
-0.08
Price / Earnings
0.24
Price / Tangible Book Value
-0.08
Enterprise Value
EUR 10.9M
Enterprise Value / EBITDA
3.45
Operating Income
EUR 4.2M
Return on Equity
92.14%
Return on Assets
31.99
Cash and Short Term Investments
EUR 1.2M
Debt
EUR 11.4M
Equity
-EUR 8.3M
Revenue
EUR 136.2K
Unlevered FCF
N/A
Sector
Biotechnology
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium